NOS2 and metabolic syndrome: This study demonstrates that in a rat model of diabetes-induced LEAD, the induction of femoral artery ultrastructural alterations and expression of vascular AGEs, ET-1, and iNOS as well as dyslipidemia and inflammation, appeared to be inhibited by metformin for a period of 12 weeks.